Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Neary

Showing results (101-110 of 148) with videos related to

Pageof 15
Sort By:
Medical Oncology (Northwood, London, England)|April 12, 2011
Safety and treatment patterns of angiogenesis inhibitors in patients with metastatic renal cell carcinoma: evidence from US community oncology clinicsBruce A Feinberg, Pradeep Jolly, Si-Tien Wang, et al.
Infectious Diseases and Therapy|January 25, 2025
Health-Related Quality of Life Among Patients Who Have Survived an Episode of Sepsis in the United States: A Systematic ReviewSanjukta Basu, Ziyan J Wei, Atara Laor, et al.
Dermatology and Therapy|December 8, 2021
Matching-Adjusted Indirect Comparison of Crisaborole Ointment 2% vs. Topical Calcineurin Inhibitors in the Treatment of Patients with Mild-to-Moderate Atopic DermatitisHoward Thom, Vincent Cheng, Edna Keeney, et al.
Dermatology and Therapy|April 13, 2021
Clinical and Economic Burden of Mild-to-Moderate Atopic Dermatitis in the UK: A Propensity-Score-Matched Case-Control StudyFarah Toron, Maureen P Neary, Timothy W Smith, et al.
Journal of Hepatology|February 24, 2001
The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivityJ G McHutchison, J E Ware, M S Bayliss, et al.
Current Medical Research and Opinion|July 10, 2009
Cost implications of IV versus oral anti-angiogenesis therapies in patients with advanced renal cell carcinoma: retrospective claims database analysisMei Sheng Duh, Ellison Dial, Toni K Choueiri, et al.
Dermatology and Therapy|October 7, 2020
Correction to: Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-AnalysisKyle Fahrbach, Jialu Tarpey, Evelien Bergrath Washington, et al.
The Journal of Surgical Research|May 23, 2001
Upregulation of Fas-Fas-L (CD95/CD95L)-mediated epithelial apoptosis--a putative role in pouchitis?J C Coffey, M W Bennett, J H Wang, et al.
Dermatology and Therapy|December 18, 2020
Clinical and Economic Burden of Pediatric Mild-to-Moderate Atopic Dermatitis: A Population-Based Nested Case-Control Study in SwedenGustaf Ortsäter, Kirk Geale, Alexander Rieem Dun, et al.
Dermatology and Therapy|May 22, 2020
Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-AnalysisKyle Fahrbach, Jialu Tarpey, Evelien Bergrath Washington, et al.
Pageof 15

Showing results (101-110 of 148) with videos related to

Sort By:
Pageof 15
Medical Oncology (Northwood, London, England)|April 12, 2011
Safety and treatment patterns of angiogenesis inhibitors in patients with metastatic renal cell carcinoma: evidence from US community oncology clinicsBruce A Feinberg, Pradeep Jolly, Si-Tien Wang, et al.
Infectious Diseases and Therapy|January 25, 2025
Health-Related Quality of Life Among Patients Who Have Survived an Episode of Sepsis in the United States: A Systematic ReviewSanjukta Basu, Ziyan J Wei, Atara Laor, et al.
Dermatology and Therapy|December 8, 2021
Matching-Adjusted Indirect Comparison of Crisaborole Ointment 2% vs. Topical Calcineurin Inhibitors in the Treatment of Patients with Mild-to-Moderate Atopic DermatitisHoward Thom, Vincent Cheng, Edna Keeney, et al.
Dermatology and Therapy|April 13, 2021
Clinical and Economic Burden of Mild-to-Moderate Atopic Dermatitis in the UK: A Propensity-Score-Matched Case-Control StudyFarah Toron, Maureen P Neary, Timothy W Smith, et al.
Journal of Hepatology|February 24, 2001
The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivityJ G McHutchison, J E Ware, M S Bayliss, et al.
Current Medical Research and Opinion|July 10, 2009
Cost implications of IV versus oral anti-angiogenesis therapies in patients with advanced renal cell carcinoma: retrospective claims database analysisMei Sheng Duh, Ellison Dial, Toni K Choueiri, et al.
Dermatology and Therapy|October 7, 2020
Correction to: Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-AnalysisKyle Fahrbach, Jialu Tarpey, Evelien Bergrath Washington, et al.
The Journal of Surgical Research|May 23, 2001
Upregulation of Fas-Fas-L (CD95/CD95L)-mediated epithelial apoptosis--a putative role in pouchitis?J C Coffey, M W Bennett, J H Wang, et al.
Dermatology and Therapy|December 18, 2020
Clinical and Economic Burden of Pediatric Mild-to-Moderate Atopic Dermatitis: A Population-Based Nested Case-Control Study in SwedenGustaf Ortsäter, Kirk Geale, Alexander Rieem Dun, et al.
Dermatology and Therapy|May 22, 2020
Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-AnalysisKyle Fahrbach, Jialu Tarpey, Evelien Bergrath Washington, et al.
Pageof 15